[Gestagens: a new method of hormonal therapy in benign prostatic hypertrophy].
D000284:Administration, Oral; D002715:Chlormadinone Acetate / Q000627:therapeutic use; D005003:Ethisterone / Q000627:therapeutic use; D005040:Ethynodiol Diacetate / Q000627:therapeutic use; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008535:Megestrol / Q000627:therapeutic use; D009640:Norethindrone / Q000627:therapeutic use; D009641:Norethynodrel / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use; D011372:Progestins / Q000008:administration & dosage / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
D006908:Hydroxyprogesterones; D011372:Progestins; D002715:Chlormadinone Acetate; D011374:Progesterone; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D008535:Megestrol; D008525:Medroxyprogesterone; D005003:Ethisterone; D009640:Norethindrone
Les gestagènes: voie nouvelle de l'hormonothérapie dans l'hypertrophie bénigne de la prostate.